Top Markets
#1 Cortex Cortex +32.55%
#2 龙虾 (Lobster) 龙虾 (Lobster) +16.86%
#3 Akedo Akedo +12.21%
#4 wojak wojak +11.93%
#5 MarsCoin MarsCoin +11.23%
#6 Pons Pons +10.45%
#7 EXOD EXOD +9.04%
#8 The Black Bull The Black Bull +7.87%
#9 Seeker Seeker +7.61%
#10 Official Trump Official Trump +6.67%
Coin of the day
Cortex Cortex
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.

300357
Clasificación en acciones #7056
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical... Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. operates as a biopharmaceutical enterprise, primarily engaged in the discovery, development, production, and sale of medicinal products. The company's core focus is on pharmaceuticals designed for the diagnosis and management of allergic conditions, which it supplies to both the Chinese domestic market and international clientele. Additionally, its portfolio encompasses various skincare lines and stem cell-related solutions. The firm's main offices are located in Huzhou, China.
Precio por acción
$3.33
Capitalización bursátil
$1.74B
Cambio (1 día)
-1.67%
Cambio (1 año)
-20.89%
País
CN
Comercio Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)

Categoría

Healthcare
Ganancias de Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -
US